Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP715167.RA-E_w6_JDkTpifzYxAc5Sva7yNwciBYgXJEoL8377Zk0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP715167.RA-E_w6_JDkTpifzYxAc5Sva7yNwciBYgXJEoL8377Zk0130_assertion type Assertion NP715167.RA-E_w6_JDkTpifzYxAc5Sva7yNwciBYgXJEoL8377Zk0130_head.
- NP715167.RA-E_w6_JDkTpifzYxAc5Sva7yNwciBYgXJEoL8377Zk0130_assertion description "[On the other hand in case of patients with pre-core/core promoter mutant type CHB, in the moderate to high HBV DNA group, 79.5% (35 patients) had minimal to mild chronic hepatitis (HAI-NI 0-8) and 20.5% (9) had moderate to severe chronic hepatitis (HAI-NI 9-18).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715167.RA-E_w6_JDkTpifzYxAc5Sva7yNwciBYgXJEoL8377Zk0130_provenance.
- NP715167.RA-E_w6_JDkTpifzYxAc5Sva7yNwciBYgXJEoL8377Zk0130_assertion evidence source_evidence_literature NP715167.RA-E_w6_JDkTpifzYxAc5Sva7yNwciBYgXJEoL8377Zk0130_provenance.
- NP715167.RA-E_w6_JDkTpifzYxAc5Sva7yNwciBYgXJEoL8377Zk0130_assertion SIO_000772 17897910 NP715167.RA-E_w6_JDkTpifzYxAc5Sva7yNwciBYgXJEoL8377Zk0130_provenance.
- NP715167.RA-E_w6_JDkTpifzYxAc5Sva7yNwciBYgXJEoL8377Zk0130_assertion wasDerivedFrom befree-20150227 NP715167.RA-E_w6_JDkTpifzYxAc5Sva7yNwciBYgXJEoL8377Zk0130_provenance.
- NP715167.RA-E_w6_JDkTpifzYxAc5Sva7yNwciBYgXJEoL8377Zk0130_assertion wasGeneratedBy ECO_0000203 NP715167.RA-E_w6_JDkTpifzYxAc5Sva7yNwciBYgXJEoL8377Zk0130_provenance.